Dutch boy unaware of being lone Libyan plane crash survivor

Tripoli (Libya), May 14 (ANI): Nine-year-old Dutch boy Ruben van Assouw managed to make it out of the crashed Afriqiyah Airways Flight 771 with two broken legs, but what he does not know still is that he is the only one to have survived out of the 104 on board.

The boy”s aunt and uncle, who traveled to Tripoli from the Netherlands to bring him home, visited his hospital room on Thursday morning.

He immediately recognized them and smiled when they came in, according to Dutch officials.

“His memory is good: as soon as his relatives walked in he smiled, and was happy to see them,” Dr. Siddiq ben Dilla was quoted by a foreign news agency, as saying.

Dutch Foreign Ministry official Ed Kronenburg said the boy remains dizzy from the after-affects of anesthesia.

“He hasn”t been told yet, as far as we know, that his parents died,” he added.

He may go home as soon as the weekend.

Dutch officials said the family has asked the media to leave them alone, despite the global interest in and sympathy for the miracle survivor. (ANI)

Diprivan side effect – Diprivan – depravan drug – diprovan drug – diprivan drip – deprevan – deprovera – propofol – diprivan side effects – versed

Diprivan side effect – Diprivan – depravan drug – diprovan drug – diprivan drip – deprevan – deprovera – propofol – diprivan side effects – versed

More questions arose Tuesday when a nurse Cherilyn Lee, a registered nurse who operates a Los Angeles-based nutritional counseling business,came forward to say that Jackson  was complaining of insomnia and requested  her to get him some Diprivan (propofol), a drug usually used to start or maintain anesthesia during surgeries.

But she  told Jackson “the medication is not safe.”

Four days before Jackson’s death, Lee said, a Jackson staffer called and said the pop star was complaining that one side of his body was hot and the other side was cold .

Nurse Cherilyn Lee, requested him to go to hospital and get treatment immediately.

She  said , “At that point, I knew that somebody had given him something that hit the central nervous system,”

she said, further, “He was in trouble Sunday and he was crying out.”

Jackson did not go to the hospital. He died June 25 after suffering cardiac arrest, his family said.

An injection of Diprivan can induce hypnosis within 40 seconds from the start of injection, according to the U.S. Food and Drug Administration.

The drug’s product label says that propofol should only be administered by people “trained in the administration of general anesthesia.” Sedated patients should be continuously monitored, the product label says, and equipment to provide artificial ventilation, administration of oxygen and instituting CPR “must be immediately available.”

The product label warns that use of propofol for sedating adult and pediatric intensive care unit patients has  been associated with organ system failures that have resulted in death.

Anaesthesia jab promises prolonged pain relief without toxicity

Washington, April 16 (ANI): A single injection may soon revolutionise the treatment of pain during and after surgery, thanks to a promising slow-release anesthetic drug-delivery system developed by researchers at Children’s Hospital Boston.

During an NIH-funded study, the researchers used specially designed fat-based particles called liposomes to package saxitoxin, a potent anesthetic, and produced long-lasting local anesthesia in rats.

The team revealed that the procedure did not seem to leave any toxic effects on nerve or muscle cells.

“The idea was to have a single injection that could produce a nerve block lasting days, weeks, maybe even months,” says Dr. Daniel Kohane, of the Division of Critical Care Medicine in the Department of Anesthesiology at Children’s, and the report’s senior author.

“It would be useful for conditions like chronic pain where, rather than use narcotics, which are systemic and pose a risk of addiction, you could just put that piece of the body to sleep, so to speak,” he added.

Kohane and his colleagues have found that when saxitoxin is packaged within liposomes, it is able to block nerve transmission of pain without causing significant nerve or muscle damage.

The researchers evaluated various types of liposomes containing saxitoxin with or without dexamethasone, a potent steroid known to augment the action of encapsulated anesthetics. They found that the best liposomes produced nerve blocks lasting two days if they contained saxitoxin alone, and seven days if combined with dexamethasone.

Upon cell culture experiments and tissue analysis, it became clear that the formulations were not toxic to muscle or nerve cells.

The researchers even examined expression of four genes known to be associated with nerve injury, and found no up-regulation.

“If these long-acting, low-toxicity formulations of local anesthetics are shown to be effective in humans, they could have a major impact on the treatment of acute and chronic pain. This slow-release technology may also have broader applications in drug delivery for the treatment of a variety of diseases,” says Dr. Alison Cole, of the NIH’s National Institute of General Medical Sciences, which partially funded the work.

Kohane’s team are presently trying to optimise the formulation so that their effects would last even longer.

“It is conceivable we could have a formulation that is suitable for clinical trials before too long,” he says.

A research paper on their work has been published online by the Proceedings of the National Academy of Sciences. (ANI)

Wrist acupuncture can prevent nausea from anesthesia

Washington, Apr 15 (ANI): A new study has found that wrist acupunture or acupressure can significantly reduce vomiting and nausea symptoms, which are generally experienced after surgery.

The researchers have found that by stimulating an acupoint called the Pericardium (P6) point in the patients’ wrists can help reduce these symptoms.

Lead researcher Anna Lee of the Department of Anesthesia and Intensive Care at The Chinese University of Hong Kong revealed that stimulating the P6 point can occur by several methods such as acupuncture or acupressure.

Acupuncture involves penetrating the skin with thin, metallic needles at defined points. One type of acupressure involves wearing a wristband that presses down on the P6 point.

“After a stimulation on the acupuncture point, the nerve system is then activated and signals the brain to release certain chemicals known as neurotransmitters, such as serotonin, dopamine or endorphins,” said Lixing Lao, a licensed acupuncturist and director at the Center for Integrative Medicine at the University of Maryland School of Medicine.

“These then block the other chemicals that cause the sickness, nausea and vomiting, in this case, in the central nerve system. Therefore, the patient won’t feel that sick or nauseated,” Lao added.

Lee and her colleague reviewed 40 studies comprising 4,858 patients. Most of the studies involved healthy adults undergoing elective surgery with general anesthesia.

The studies compared the stimulation of the P6 acupoint with sham (placebo) treatment or anti-nausea or antiemetics drug

“Of the 40 trials included, the most common method of stimulation was wristband alone, in 17 studies,” said Lee.

“The wristbands used to prevent both postoperative nausea and vomiting are the same sold for seasickness, travel sickness, morning sickness and chemotherapy-related nausea and vomiting,” she added.

Lee said “for 100 people, of whom 80 would vomit or feel sick after surgery if given sham treatment, about 25 people would benefit from P6 stimulation and 75 would not.”

She said that reducing nausea and vomiting for surgery patients through P6 point stimulation could reduce costs, such as the cost of antiemetic medication and length of hospital stays, and improve the quality of patient care.

The review appears in the current issue of The Cochrane Library. (ANI)

Cochlear implant surgery is safe for the elderly

Washington, March 1 (ANI): Healthy elderly patients with severe to profound hearing loss can undergo a surgical procedure to receive cochlear implants with minimal risk, says an Indian-origin researcher.

“Due to concerns about the effects of general anesthesia, many elderly people with hearing loss are not receiving the implants which can significantly improve their hearing and quality of life,” says Dr. Anil Lalwani, Mendik Foundation Professor of Otolaryngology and Chairman of the Department of Otolaryngology at NYU School of Medicine and a study co-author.

“The elderly are often incorrectly considered too fragile for this life transforming technology that can deliver them from a world of silence and loneliness to a world of hearing and engagement,” he adds.

According to a research article published in the journal The Laryngoscope, the researchers conducted a retrospective chart review of 70 patients over 70 years of age who received cochlear implants under general anesthesia at NYU Langone Medical Center between 1984 and 2007.

The researchers revealed that the patients were divided into risk groups, and intraoperative and postoperative anesthesia-related complications were identified.

They observed that most patients tolerated the procedure, and there was no long-term morbidity or mortality related to the surgery or anesthesia.

Based on their observations, the researchers came to the conclusion that general anesthesia is well tolerated by elderly patients undergoing cochlear implantation.

They said that any pre-existing medical condition is a better predictor of intraoperative and postoperative complication than age alone.

Dr. Jung T. Kim, Vice chairman of the Department of Anesthesiology at NYU School of Medicine and a study co-author said: “As seniors embrace a healthy and active lifestyle, it is important that age alone should not deter a person from having surgery that could potentially improve their quality of life.” (ANI)

Cochlear implant surgery is safe for the elderly

Washington, March 1 (ANI): Healthy elderly patients with severe to profound hearing loss can undergo a surgical procedure to receive cochlear implants with minimal risk, says an Indian-origin researcher.

“Due to concerns about the effects of general anesthesia, many elderly people with hearing loss are not receiving the implants which can significantly improve their hearing and quality of life,” says Dr. Anil Lalwani, Mendik Foundation Professor of Otolaryngology and Chairman of the Department of Otolaryngology at NYU School of Medicine and a study co-author.

“The elderly are often incorrectly considered too fragile for this life transforming technology that can deliver them from a world of silence and loneliness to a world of hearing and engagement,” he adds.

According to a research article published in the journal The Laryngoscope, the researchers conducted a retrospective chart review of 70 patients over 70 years of age who received cochlear implants under general anesthesia at NYU Langone Medical Center between 1984 and 2007.

The researchers revealed that the patients were divided into risk groups, and intraoperative and postoperative anesthesia-related complications were identified.

They observed that most patients tolerated the procedure, and there was no long-term morbidity or mortality related to the surgery or anesthesia.

Based on their observations, the researchers came to the conclusion that general anesthesia is well tolerated by elderly patients undergoing cochlear implantation.

They said that any pre-existing medical condition is a better predictor of intraoperative and postoperative complication than age alone.

Dr. Jung T. Kim, Vice chairman of the Department of Anesthesiology at NYU School of Medicine and a study co-author said: “As seniors embrace a healthy and active lifestyle, it is important that age alone should not deter a person from having surgery that could potentially improve their quality of life.” (ANI)

Nausea drug may help treat opioid addiction

Washington, Feb 18 (ANI): A drug commonly used for treating nausea and vomiting can help prevent severe withdrawal symptoms from opioids, according to a new study.

The research team from Stanford University School of Medicine have found that addicts of heroin and prescription drugs such as codeine and morphine might be able to break their dependence without severe withdrawal symptoms or side effects with the help of drug, ondansetron.

“Opioid abuse is rising at a faster rate than any other type of illicit drug use, yet only about a quarter of those dependent on opioids seek treatment,” said Dr Larry F. Chu, assistant professor of anesthesia at the School of Medicine and lead author of the study

“One barrier to treatment is that when you abruptly stop taking the drugs, there is a constellation of symptoms associated with withdrawal,” he added.

Chu described opioid withdrawal as a “bad flu,” characterized by agitation, insomnia, diarrhea, nausea and vomiting.

Chu said that current methods used for treatment are not completely effective.

“What we need is a magic bullet,” said Chu.

“Something that treats the symptoms of withdrawal, does not lead to addiction and can be taken at home,” he added.

The researchers found that drug ondansetron can block certain receptors involved in withdrawal symptoms.

During the study, the researchers recruited eight non-opioid-dependent humans. In one session, they received only a single large dose of morphine, and in another session that was separated by at least week, they took ondansetron in combination with morphine.

They found that humans treated with ondansetron before or while receiving morphine showed a significant reduction in withdrawal signs compared with when they received morphine but not ondansetron.

The study is published in the Journal of Pharmacogenetics and Genomics. (ANI)

Osteoblast cell injections may speed up fracture healing

Washington, Feb 12 (ANI): Osteoblast cell obtained from a patient’s own bone marrow can help quicken the healing of a long bone fracture, according to a new study.

Dr Seok-Jung Kim from the Catholic University College of Medicine, Seoul, involved 64 patients in their study, of which 31 were given the ‘Osteoblast’ treatment and 33 left to recover the normal way.

The researchers observed that the patients injected with the ‘osteoblast cell’ healed faster that the normally treated ones.

“The cultured osteoblast injection group showed fracture healing acceleration of statistical significance, and there were no specific patient complications when using this treatment. Cultured osteoblast injection should therefore be considered as a successful treatment option for long-bone fracture,” Dr. Kim said.

“There was significantly more bone growth in the experimental group, compared to the control group. Autologous cultured osteoblast transplant is a safe and effective method for accelerating the rate of fracture healing,” he added.

Dr. Kim points out that the bone union process is often left to natural healing, and such cases are generally so delayed that they eventually need bone transplants.

The researcher says that ‘Osteoblast cell’ injections can prove beneficial in such cases.

“Time has increasingly become the most important factor in clinical decision-making. While fractures generally will eventually heal, bone union can frequently be delayed to the extent that it requires bone transplantation. Not only does this cause psychological and physical pain to the individual patient, it’s also not economically viable,” Dr. Kim said.

“Although bone transplant remains the most effective method of bone union, osteoblast injections provide an alternative which can be performed under local anesthesia with no requirement for surgery,” Dr. Kim added.

The study has been published in the open access journal BMC Musculoskeletal Disorders. (ANI)

Antidepressants pose risks to cosmetic surgery patients

Washington, Jan 6 (ANI): A research team from New York has found that using common antidepressants and herbal medications may have potentially harmful intraoperative effects on patients undergoing cosmetic surgical procedures.

The researchers conducted and reviewed case studies regarding the effects of the 29 most commonly used herbs and antidepressants, on anesthesia and surgery.

They identified a number of harmful, intraoperative risks, ranging from increased bleeding to fatal interactions.

The researchers have established recommendations for the management of these medications before elective surgery.

They suggest that patients using those antidepressants and herbs noted in the study consult with the prescribing physician about discontinuing use for up to two weeks prior to surgery.

This study appears in the January 2009 issue of Plastic and Reconstructive Surgery. (ANI)

Home